Primun non nocere
Artículo barra lateral
PDF
Publicado
Apr 28, 2017
Sección: Sobre Medicamentos
¿Cómo citar?
Echeverry Raad, J. (2017). Primun non nocere. Carta Comunitaria, 25(143), 89-92. https://doi.org/10.26752/ccomunitaria.v25.n143.88
Formatos de citación
Contenido principal del artículo
Autores
Jairo Echeverry Raad
Detalles del artículo
Referencias
(1) Del Río L, Soto SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, et al. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS ONE. 2016; 11(11): e0166502. doi:10.1371/journal.pone.0166502
(2) Pimenta J, Borges I. Efficacy of the Vaccines against Human Papillomavirus in Women Older than 24 Years in the Cervix Cancer Prevention. Acta Med Port. 2016; 29(6): 401-408. doi: 10.20344/amp.7095. Epub 2016 Jun 30.
(3) Francis T. Evaluation of the 1954 Poliomyelitis Vaccine Field Trialfurther Studies of Results Determining the Effectiveness of Poliomyelitis Vaccine (Salk) in Preventing Paralytic Poliomyelitis. JAMA. 1955; 158(14):1266-1270. doi:10.1001/jama.1955.02960140028004
(4) Centers for Disease Control and Prevention (CDC). Withdrawal of Rotavirus Vaccine Recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007.
(2) Pimenta J, Borges I. Efficacy of the Vaccines against Human Papillomavirus in Women Older than 24 Years in the Cervix Cancer Prevention. Acta Med Port. 2016; 29(6): 401-408. doi: 10.20344/amp.7095. Epub 2016 Jun 30.
(3) Francis T. Evaluation of the 1954 Poliomyelitis Vaccine Field Trialfurther Studies of Results Determining the Effectiveness of Poliomyelitis Vaccine (Salk) in Preventing Paralytic Poliomyelitis. JAMA. 1955; 158(14):1266-1270. doi:10.1001/jama.1955.02960140028004
(4) Centers for Disease Control and Prevention (CDC). Withdrawal of Rotavirus Vaccine Recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007.
Descargas
La descarga de datos todavía no está disponible.
